Praxis Precision Medicines (PRAX) Earnings Date & Reports
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PRAX is expected to report earnings to rise 14.69% to -367 cents per share on August 10
Q2'26
Est.
$-3.67
Q1'26
Beat
by $0.40
Q4'25
Missed
by $0.41
Q3'25
Beat
by $0.11
Q2'25
Missed
by $0.06
The last earnings report on May 07 showed earnings per share of -320 cents, beating the estimate of -359 cents. With 423.17K shares outstanding, the current market capitalization sits at 7.43B.